Zummo Jacqueline — SEC Form 4 filings
SEC reporting owner CIK 1798929. 12 Form 4 filings on record with FilingPulse; latest filed 2026-04-09.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-12 to 2026-04-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 44,956 shares, $221,134 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 22,598 shares @ $5.26 ($118,865) in Protara Therapeutics, Inc., filed 2026-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | Chief R&D Officer | 12 | — | 3 legs · 44,956 sh · $221,134 | 12 |
Form 4 filings — Zummo Jacqueline
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-09 | 4 | Protara Therapeutics, Inc. (TARA) | Sale (S): 1,134 @ $5.40 | EDGAR |
| 2026-04-02 | 4 | Protara Therapeutics, Inc. (TARA) | Sale (S): 22,598 @ $5.26 | EDGAR |
| 2026-01-27 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 3,724 @ $6.67 | EDGAR |
| 2026-01-22 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 6,578 @ $5.60 | EDGAR |
| 2026-01-21 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4/A | Protara Therapeutics, Inc. (TARA) | Holdings only — no transactions reported | EDGAR |
| 2025-03-28 | 4 | Protara Therapeutics, Inc. (TARA) | Sale (S): 21,224 @ $4.53 | EDGAR |
| 2025-01-28 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 24,500 @ $0 · Grant/award (A): 146,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 6,554 @ $4.76 | EDGAR |
| 2025-01-07 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 2,157 @ $6.14 | EDGAR |
| 2024-01-23 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 23,000 @ $0 · Tax withholding (F): 3,049 @ $1.91 · Grant/award (A): 137,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 5,229 @ $2.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1798929 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →